COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 51: Articles 501-510  | Next

Menstrual cycle phase and its association with COVID-19 vaccine side effects and subsequent infection: A study of period tracking app users.
Cooper, P. A., Boniface, E., Darney, B., Edelman, A., Sear, R., Shea, A., Vitzthum, V., Walters, S., Weber, K., Alvergne, A.
10.1101/2025.11.26.25341088 — Posted: 2025-11-30
Interaction and co-phase separation of SARS-CoV-2 nucleocapsid protein and human hnRNPA1 and its implications for viral life cycle
Gupta, P., Sahu, R., Nandi, I., Setty, S. R. G., Das, S., Singh, M.
10.1101/2025.11.28.691101 — Posted: 2025-11-28
Cross-Program Secondary Analyses and Public Health Innovation: The RADx Data Hub as a Resource for Integrated COVID-19 Research
Smith, K., Rose, P. W., Rivas, T., Mehri, N., Alonso Lozoya, O., Jeffers-Francis, L., King, M. D., Akdogan, M. U., Snipe, J., Farlow, B., Keller, M. A., Musen, M. A., Suber, S., Krishnamurthy, A.
10.1101/2025.11.26.25341110 — Posted: 2025-11-28
The Cost of Distrust: Governance Perceptions, Risk, and COVID-19 Vaccine Uptake in Africa--Evidence from the Afrobarometer Survey
Adda, R., Pwayirane, C.
10.1101/2025.11.26.25341108 — Posted: 2025-11-28
Development of Diagnostic Real-Time RT-PCR Assays for SARS-CoV-2 Using Polyvinyl Alcohol (PVA) Sponge as a Saliva Collection Tool
Kinoshita, K., Kisoi, M., Shinozuka, K., Sasaki, T., Shioda, T., Ichikawa, A.
10.1101/2025.11.24.25340856 — Posted: 2025-11-27
Asymptomatic infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients
Shih, C., Liao, Y.-Z., Hsu, C.-Y., Tsai, Y.-C., Lin, M.-Y., Chiou, H.-Y. C., Kuan, W.-H., Chang, C.-H., Liou, A.-T., Chou, Y.-C., Sheen, F.-Z., Lin, H.-J., Tsai, J.-J., Lin, P.-C., Yu, M.-L., Chuang, W.-L., Lee, J.-J., Chang, J.-M., Hwang, S.-J., Shih, J., Hung, W.-C., Hou, M.-F., Chong, I.-W., Jong, Y.-J., Chang, J.-S.
10.1101/2025.11.26.25341060 — Posted: 2025-11-27
Perceived stress and associated societal, community, interpersonal, and individual factors in adults with post-COVID-19 condition: the PRIME study.
Wijnen, S. M., van Bilsen, C. J., Pagen, D. M., Koster, A., Hoebe, C. J., Dukers-Muijrers, N. H.
10.1101/2025.11.24.25340916 — Posted: 2025-11-27
Characterizing spatiotemporal patterns of case reporting backfill: a case study of COVID-19 reporting in Michigan, 2020-24
Niu, Y., Brouwer, A. F., Martin, E. T., Coyle, J. R., Eisenberg, M. C.
10.1101/2025.11.25.25340977 — Posted: 2025-11-27
Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination
Georgiou, I., O'Neill, S., Robinson, C., Cunningham, F., O'Byrne, S. N., Gray, D., Scott, D. E., Gilbert, I. H.
10.1101/2025.11.27.690678 — Posted: 2025-11-27
Crystallographic Ensembles Reveal the Structural Basis of Binding Entropy in SARS-CoV2 Macrodomain
Seo, L., Farran, I., Aslam, A., Li, X., Jaishankar, P., Fraser, J. S., Renslo, A., Wankowicz, S. A.
10.1101/2025.11.25.690589 — Posted: 2025-11-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).